Neuroscientific Biopharmaceuticals Ltd (NSB) — Capital Reinvestment Ratio

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (AU$1.62 Million) in capital expenditures (AU$1.82K). See Neuroscientific Biopharmaceuticals Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Data as of

Jun 2024

Most recent filing

Neuroscientific Biopharmaceuticals Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Neuroscientific Biopharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. Check NSB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Neuroscientific Biopharmaceuticals Ltd from 2024 to 2024. For live market cap and broader valuation context, see NSB stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.04x	AU$44.25K	AU$1.81K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow